By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



CHNO des Quinze-Vingts
Résidence Saint Louis
Cedex    75571  France
Phone: 33-1-56-95-05-60 Fax: 33-1-56-95-05-69



Company News
Neurotech Achieves Major Milestone With First Shipment Of Mente Autism Devices 12/22/2016 10:03:11 AM
Neurotech Announces Launch Of New Website 12/13/2016 7:33:27 AM
Neurotech Launches Mente Autism 11/11/2016 9:41:35 AM
Neurotech Closes First Day On ASX At 42.5% Premium 11/4/2016 3:54:26 PM
Neurotech Announces First Patient Enrolled In Novel Anti-VEGF Encapsulated Cell Therapy Study 9/2/2015 8:04:21 AM
Neurotech Announces FDA Acceptance Of Investigational New Drug Application And Clinical Trial Initiation Of Novel Therapy For Wet AMD 3/30/2015 9:08:04 AM
Neurotech Announces Appointment Of Dr. Charles Johnson As Chief Medical Officer 3/18/2015 9:28:56 AM
Cognoptix President And CEO Paul Hartung Tells Neurotech Investors: "Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care." 4/25/2014 9:54:45 AM
Neurotech, To Present At Biotech Showcase 2014 In San Francisco 1/6/2014 7:09:33 AM
Neurotech Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies 9/19/2013 10:08:34 AM